Third Rock Ventures V, L.P.
Third Rock Ventures V, L.P.'s purchase track record
Third Rock Ventures V, L.P. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/28/2024 | SEPN | $11.70M | -22.1% | -66.3% | -5.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Guggenheim initiates coverage of Rapport Therapeutics, sets $65 target. Guggenheim began coverage of Rapport Therapeutics and assigned a price target of $65. The target sits above the company's 52‑week high of $52.93, indicating a positive outlook. The stock currently trades with a low RSI and near a strong support level, which may influence market reaction to the new estimate.
Transaction History
| SEPN | ▼ Sell | Open Market | 141 | $7K | 8/12/2026 | View on chart |
| SEPN | ▼ Sell | Open Market | 147,059 | $7.4M | 8/12/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 18,572 | $744K | 5/26/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 133,618 | $5.4M | 5/11/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 5,018 | $202K | 5/8/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 271,495 | $10.9M | 5/7/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 426,005 | $17.2M | 4/17/2026 | View on chart |
| SEPN | ▼ Sell | Other | 4,790,773 | $0 | 10/28/2024 | View on chart |
| SEPN | ▼ Sell | Other | 2,872,956 | $0 | 10/28/2024 | View on chart |
| SEPN | ▲ Buy | Open Market | 370,500 | $6.7M | 10/28/2024 | View on chart |
| SEPN | ▲ Buy | Open Market | 279,500 | $5.0M | 10/28/2024 | View on chart |
| RAPP | ▼ Sell | Other | 6,551,449 | $0 | 6/10/2024 | View on chart |
| RAPP | ▼ Sell | Other | 969,218 | $0 | 6/10/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Septerna Schedules Upcoming Investor Conference Appearances
Septerna announced plans to participate in upcoming investor conferences. Such events are routine for publicly traded companies and provide opportunities for management to engage with institutional investors and analysts. The conferences may include presentations and one-on-one meetings, though no specific details about agenda topics were disclosed.
Septerna Schedules Upcoming Investor Conference Appearances. Septerna announced plans to participate in upcoming investor conferences. Such events are routine for publicly traded companies and provide opportunities for management to engage with institutional investors and analysts. The conferences may include presentations and one-on-one meetings, though no specific details about agenda topics were disclosed.